Home » Topics » Regulatory

Regulatory
RSS

Rogaine Extra Strength for Men recommended for approval as OTC

July 21, 1997

FDA clears new indication and new labeling for Zoloft

July 18, 1997

Ganciclovir implant effective in treating CMV retinitis

July 17, 1997

RPR launches room-temperature formulation of DDAVP

July 16, 1997

Athena Neurosciences and Wyeth-Ayerst copromote Naprelan

July 16, 1997

RiboGene signs marketing agreement for intranasal metoclopramide

July 16, 1997

Mianserin studied for treatment of sexual dysfunction

July 16, 1997

Bigmar submits ANDA for leucovorin

July 15, 1997

Teva receives FDA approval for generic estazolam

July 15, 1997

FDA approves antibacterial generic from Mylan

July 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.